Insider Transactions in Q4 2022 at Chemo Centryx, Inc. (CCXI)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Oct 20
2022
|
Thomas J. Schall President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,393,352
-100.0%
|
-
|
Oct 20
2022
|
Joseph M Feczko Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
148,127
-100.0%
|
-
|
Oct 20
2022
|
James L Tyree Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
9,138
-100.0%
|
-
|
Oct 20
2022
|
Susan M Kanaya Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
132,717
-100.0%
|
-
|
Oct 20
2022
|
Susan M Kanaya Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
91,317
-100.0%
|
-
|
Oct 20
2022
|
Geoffrey M. Parker Director |
SELL
Sale (or disposition) back to the issuer
|
Indirect |
26,076
-100.0%
|
-
|
Oct 20
2022
|
Geoffrey M. Parker Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
107,997
-100.0%
|
-
|
Oct 20
2022
|
Thomas A. Edwards Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
143,306
-100.0%
|
-
|
Oct 20
2022
|
Jennifer Lyn Herron Director |
SELL
Sale (or disposition) back to the issuer
|
Direct |
17,237
-100.0%
|
-
|
Oct 20
2022
|
Rita Jain EVP, Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
35,863
-100.0%
|
-
|
Oct 20
2022
|
Tausif Butt EVP, Chief Operating Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
10,870
-100.0%
|
-
|
Oct 20
2022
|
Markus J. Cappel Chief Bus. Officer & Treasurer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
87,658
-100.0%
|
-
|